151 related articles for article (PubMed ID: 34987803)
1. Melanin-producing medullary thyroid carcinoma with transformation to melanoma: A case report.
Yoshikawa KI; Tanimura T; Hoshi M; Fukumori T; Shimizu K; Ishii S; Onose H; Yamada E; Sugishita Y; Suzuki S; Hirokawa M; Miyauchi A; Yamada T
Mol Clin Oncol; 2022 Feb; 16(2):34. PubMed ID: 34987803
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma arising in melanin-producing medullary thyroid carcinoma.
Hirokawa M; Miyauchi A; Otsuru M; Daa T
Int J Surg Case Rep; 2016; 20():118-22. PubMed ID: 26852361
[TBL] [Abstract][Full Text] [Related]
3. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
[TBL] [Abstract][Full Text] [Related]
4. Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.
Greco C; Brigante G; Taliani E; Corrado S; Simoni M; Madeo B
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778356
[TBL] [Abstract][Full Text] [Related]
5. HRAS-mutated primary thyroid malignant melanoma or medullary thyroid carcinoma with melanocytic dedifferentiation? A singular case with an ontogeny-phylogeny quandary.
Subramanian P; Deshmukh A; Kante K; Patil A; Pai T; Kaur R; Rane S; Shetty O; Ankathi SK; Mittal N
Virchows Arch; 2023 Sep; 483(3):421-429. PubMed ID: 37550582
[TBL] [Abstract][Full Text] [Related]
6. Cytological aspects of melanotic variant of medullary thyroid carcinoma.
de Lima MA; Dias Medeiros J; Rodrigues Da Cunha L; de Cássia Caldas Pessôa R; Silveira Tavares F; de Fátima Borges M; Marinho EO
Diagn Cytopathol; 2001 Mar; 24(3):206-8. PubMed ID: 11241906
[TBL] [Abstract][Full Text] [Related]
7. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
8. Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review.
Chen L; Zhao K; Li F; He X
Front Oncol; 2020; 10():526716. PubMed ID: 33194586
[TBL] [Abstract][Full Text] [Related]
9. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.
Rafaey W; Munir Alvi A; Siddiqi AI; Shafiq W; Irfan H
Cureus; 2022 Nov; 14(11):e32088. PubMed ID: 36600874
[TBL] [Abstract][Full Text] [Related]
11. Pathological characteristics and genetic features of melanin-producing medullary thyroid carcinoma.
Wang C; Yun T; Wang Z; Meng N; Fan N; Lv X; Li F
Diagn Pathol; 2018 Nov; 13(1):86. PubMed ID: 30424779
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract][Full Text] [Related]
13. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
[TBL] [Abstract][Full Text] [Related]
14. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
15. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
17. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
18. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
19. Melanotic medullary carcinoma of thyroid--report of a rare case with brief review of literature.
Singh K; Sharma MC; Jain D; Kumar R
Diagn Pathol; 2008 Jan; 3():2. PubMed ID: 18190715
[TBL] [Abstract][Full Text] [Related]
20. Melanin-producing medullary thyroid carcinoma with glandular differentiation.
Kimura N; Ishioka K; Miura Y; Sasano N; Takaya K; Mouri T; Kimura T; Nakazato Y; Yamada R
Acta Cytol; 1989; 33(1):61-6. PubMed ID: 2644744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
